Market News & Trends
CPHI Broadens European Strategy With New Spain Event and Specialist Frankfurt Zones
CPHI is expanding its European event portfolio in 2027, adding a new country-focused pharmaceutical exhibition in Spain while expanding its flagship Frankfurt event into several…
Upperton Unveils New Brand as it Expands Specialist CDMO Offering
Nottingham, UK-based pharmaceutical development and manufacturing company Upperton Pharma Solutions has introduced a new brand identity as it enters a new stage of growth, positioning…
Ofichem to Acquire Kinentia Biosciences, Expanding US Drug Substance Footprint
Ofichem is set to establish its first operational presence in the US drug substance market through an agreement to acquire New York-based CDMO Kinentia Biosciences.…
SGD Pharma Broadens Glass Vial Portfolio With New Nasal and RTU Offerings
SGD Pharma is expanding its pharmaceutical glass packaging portfolio with new molded and tubular vial solutions aimed at drug developers working with high-value and increasingly…
CPHI Milan Brings Pharma Industry Together for Practical Sustainability Summit
Pharmaceutical companies, suppliers and sustainability specialists will gather in Milan at CPHI this week for a new industry forum aimed at moving sustainability discussions from…
Agilent Adds Boulder Lab to Expand Oligonucleotide Manufacturing Capabilities
Agilent Technologies is expanding its oligonucleotide manufacturing infrastructure with a new laboratory in Boulder, Colorado, aimed at advancing and scaling emerging production technologies for oligonucleotide…
Credence MedSystems Earns ISO 13485 Certification as it Expands Drug Delivery Manufacturing Readiness
Credence MedSystems has secured ISO 13485:2016 certification for its quality management system, a milestone the drug-delivery technology company says strengthens its position as a potential…
Novartis Pays $575M Upfront for Abogen's mRNA T-Cell Engager
Novartis has agreed to pay Abogen Biosciences $575 million upfront for worldwide rights to an experimental mRNA-encoded T-cell engager, in a deal that could reach…
Lifecore Biomedical to Be Acquired by Webster Equity Partners in Deal Valued at Up to $663.7M
Lifecore Biomedical has agreed to be acquired by private equity firm Webster Equity Partners in a transaction that could be worth as much as $663.7…
Lonza and Asimov Team Up to Tackle In Vivo Lentiviral Manufacturing Challenges
Lonza and Asimov have entered into a strategic collaboration focused on developing scalable manufacturing approaches for lentiviral vectors (LVVs) intended for emerging in vivo applications.…
Adare Partners With OnDosis on Precision-Dosing Platform for ADHD Treatment
OnDosis and Adare Pharma Solutions have entered into a strategic collaboration aimed at advancing OnDosis' lead U.S. drug-development program for attention-deficit/hyperactivity disorder (ADHD). Under the…
Johnson & Johnson Reports Two-Year Icotrokinra Data in High-Impact Plaque Psoriasis
Johnson & Johnson has reported two-year results from the Phase 3 ICONIC-TOTAL study showing sustained improvements in skin clearance among adults and adolescents with plaque…
Lonza Expands Aseptic Spray Drying Platform for High-Dose Biologics
Lonza is expanding development of an aseptic spray drying platform designed to address some of the formulation and delivery challenges associated with highly concentrated biologic…
Ensera Launches Alliance Network to Support Combination-Product Commercialization
Ensera has launched a new alliance network designed to help pharmaceutical companies navigate the commercialization of injectable drug-device combination products. The Ensera Alliance Network brings…
Gattefossé Adds Vitamin E TPGS and Solid Surfactants to Oral Drug Delivery Portfolio
Gattefossé is expanding its pharmaceutical excipient portfolio with the commercial launch of Vitamin E TPGS and the introduction of a new range of solid surfactants…
ESTEVE CDMO Commits Additional $17.5M to Expand U.S. Manufacturing Capacity
ESTEVE CDMO is expanding its manufacturing and development capabilities in the United States with a further $17.5 million investment at its Morton Grove, Illinois facility.…
Johnson & Johnson Highlights New Two-Year Data and Real-World Insights for IMAAVY®
Johnson & Johnson (JNJ) announced new findings on IMAAVY® (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) across 15 novel abstracts to be presented…
Credence MedSystems Reaches ISO 13485 Certification Milestone, Expanding Readiness for Commercial Drug Delivery Partnerships
Credence MedSystems, a developer of drug delivery technologies for pharmaceutical and biotechnology companies, has achieved ISO 13485:2016 certification for its Quality Management System, marking an…
Axplora Advances European Exatecan Supply for ADC Developers
Axplora has completed its initial R&D batches of Exatecan as it moves forward with Axotecan, an initiative designed to establish an independent European supply source…
Ginkgo Datapoints and Apheris Launch Industry Consortium to Advance AI-Powered Antibody Developability
Ginkgo Datapoints, an offering of Ginkgo Bioworks, and Apheris GmbH today announced that the Antibody Developability Consortium has kicked-off with its founding members. The Consortium…
